ORGS · As filed with the SEC
Orgenesis income statement, by quarter
The statement as Orgenesis presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Comprehensive Loss (Income) · USD thousands, except per-share amounts
| USD thousands, except per-share amounts | Q4 2024† 3 months ended Dec 31, 2024 | Q3 2024† 3 months ended Sep 30, 2024 | Q2 2024† 3 months ended Jun 30, 2024 | Q1 2024 3 months ended Mar 31, 2024 |
|---|---|---|---|---|
| Customer D (United States) | 301† | 347 | 246 | 141 |
| Cost of Revenue | 313† | 585 | 538 | 492 |
| Gross loss | (12)† | (238) | (292) | (351) |
| Research and Development Expense | 1,240† | 4,523 | 1,489 | 2,370 |
| Amortization of Intangibles | 153† | 196 | 226 | 153 |
| Change in Contingent consideration | (4,906)† | 81 | 182 | — |
| Selling, General and Administrative Expense | 4,041† | 2,664 | 2,061 | 6,056 |
| Asset Impairment Charges | — | 692 | — | — |
| Operating loss | 18,194† | 8,394 | 4,250 | 8,930 |
| Loss (profit) from deconsolidation of OBI, Korea, Belgium, Services and Octomera (see note 3 and note 20) | (4,546)† | 0† | 0† | 66 |
| Other income, net | (720)† | 122 | (8) | — |
| Loss from extinguishment in connection with loans | 5,281† | 0† | 0† | 141 |
| Financial expenses, net | 2,123† | 718 | 815 | 852 |
| Convertible loans induced conversion expenses | — | 0† | 4,304 | — |
| Loss before income taxes | 20,332† | 9,234 | 9,361 | 9,989 |
| Income Tax Expense | 44† | 32 | 5 | 16 |
| Net loss | 20,376† | 9,266 | 9,366 | 10,005 |
| Net Income Attributable to Noncontrolling Interest | 0† | (146) | (462) | (240) |
| Net loss attributable to Orgenesis Inc. | 20,376† | 9,120 | 8,904 | 9,765 |
| Earnings Per Share (Basic) | — | 1.93 | 0.23 | 0.29 |
| Earnings Per Share (Diluted) | — | 1.93 | 0.23 | 0.29 |
| Shares Outstanding | ||||
| Basic | — | 4,715,229 | 38,860,727 | 33,176,657 |
| Diluted | — | 4,715,229 | 38,860,727 | 33,176,657 |
| Net loss | — | 9,266 | 9,366 | 10,005 |
| Comprehensive loss: | ||||
| Other Comprehensive loss – Translation adjustment | (1,133)† | 517 | (176) | (61) |
| Comprehensive loss | — | 9,783 | 9,190 | 9,944 |
| Comprehensive loss attributed to non-controlling interests | — | (146) | (462) | (240) |
| Comprehensive loss attributed to Orgenesis Inc. | 19,777† | 9,637 | 8,728 | 9,704 |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.